AstraZeneca Presents Results From Positive Phase 3 TULIP 2 Trial For Anifrolumab
Sandoz Presents Interim Analysis From COMPACT Study
Beximco Pharma FY Net Sales Up 28.8% To £212.7 Mln
Eco Animal Health Says H1 Trading Results To Be Below Last Year
Sandoz Agrees To Acquire Aspen's Japanese Operations And Associated Assets
Genentech's Risdiplam Meets Primary Endpoint In Pivotal SUNFISH Trial
AstraZeneca Presents Results From Phase III OLYMPUS And ROCKIES Trials
National Vision Holdings Q3 EPS $0.01 Vs $0.06 Last Year